| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2767537 | Regional Anesthesia and Pain Medicine | 2006 | 9 Pages |
Abstract
Compared with placebo, perioperative administration of rofecoxib 50 mg provided significant opioid sparing, significantly better pain control, improved clinical outcomes, and was well tolerated.
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
Raymond S. M.D., Ph.D., Judith A. Ph.D., Tom L. Ph.D., Amy T. M.P.H., Maureen M. B.S., Jonathan S. M.D., Steven M.D., Neil M.D., Paul F. Ph.D., Alise S. M.D., Protocol 159 Study Group Protocol 159 Study Group,